Skip to content
10-K

Annual Report

SCOPUS BIOPHARMA INC.

0001410578-23-000666

← back to feed
Filed
Apr 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Apr 10, 2023 39.58M sh
Shares Diluted FY 2022 · Dec 31, 2022 21.09M sh
Shares Diluted FY 2022 · Dec 31, 2021 17.25M sh
Capex FY 2022 · Dec 31, 2022 $1.55K
Capex FY 2022 · Dec 31, 2021 $2K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$8.13M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$11.42M
Cash And Equivalents FY 2022 · Dec 31, 2022 $124.58K
Cash And Equivalents FY 2022 · Dec 31, 2021 $7.94M
Stockholders Equity FY 2022 · Dec 31, 2022 −$6.56M
Stockholders Equity FY 2022 · Dec 31, 2021 $4.02M
Current Liabilities FY 2022 · Dec 31, 2022 $7.45M
Current Liabilities FY 2022 · Dec 31, 2021 $4.17M
Current Assets FY 2022 · Dec 31, 2022 $390K
Current Assets FY 2022 · Dec 31, 2021 $8.18M
Total Assets FY 2022 · Dec 31, 2022 $392.27K
Total Assets FY 2022 · Dec 31, 2021 $8.19M
Eps Diluted FY 2022 · Dec 31, 2022 −$0.55
Eps Diluted FY 2022 · Dec 31, 2021 −$1.56
Eps Basic FY 2022 · Dec 31, 2022 −$0.55
Eps Basic FY 2022 · Dec 31, 2021 −$1.56
Sga Expense FY 2022 · Dec 31, 2022 $9.03M
Sga Expense FY 2022 · Dec 31, 2021 $12.61M
Rd Expense FY 2022 · Dec 31, 2022 $2.68M
Rd Expense FY 2022 · Dec 31, 2021 $15.02M
Net Income FY 2022 · Dec 31, 2022 −$11.61M
Net Income FY 2022 · Dec 31, 2021 −$26.95M
Operating Income FY 2022 · Dec 31, 2022 −$11.71M
Operating Income FY 2022 · Dec 31, 2021 −$27.63M
Revenue FY 2022 · Dec 31, 2022 $0
Revenue FY 2022 · Dec 31, 2021 $0